Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms

Authors

DOI:

https://doi.org/10.1590/1809-2950/19018827022020

Keywords:

Doença Pulmonar Obstrutiva Crônica;, Dispneia, Depressão

Abstract

This cross-sectional study assessed the activities of daily living (ADL) and risk factors for developing depressive symptoms in patients with chronic obstructive pulmonary disease (COPD) and was carried out at the pulmonology outpatient clinic of the Hospital Universitário Oswaldo Cruz. Two hundred two (202) patients with COPD participated in the study. We evaluated the sociodemographic and anthropometric data, the ADL by means of Pulmonary Functional Status and Dyspnea Questionnaire - Modified version (PFSDQ-M), and the presence of depressive symptoms using the Beck Depression Inventory (BDI). All domains (dyspnea, fatigue and activity changes) of PFSDQ are compromised in patients with depressive symptoms. The prevalence of depressive symptoms was 38.6%. The chance of developing these symptoms was higher for those who used more than one bronchodilator (OR: 2.82, CI 95%: 1.47-5.38, p=0.002), presented dyslipidemias (OR: 2.74, CI95%: 1.24-6.07, p=0.012), had a heart disease (OR: 2.82, CI 95%: 1.18-6.74, p=0.020), presented expectoration (OR: 2.44, CI 95%: 1.2-4.95, p=0.014) or did not have a partner (OR: 2.58, CI 95%: 1.36-4.9, p=0.004). COPD patients with depressive symptoms had all domains of ADL compromised compared to patients without these symptoms.

Downloads

Download data is not yet available.

References

Barnes PJ, Celli BR. Systemic manifestations and

comorbidities of COPD. Eur Respir J. 2009;33:1165-85.

doi: 10.1183/09031936.00128008

Weldam SWM, Lammers JWJ, Decates RL, Schuurmans MJ.

The daily activities and quality of health of life in patients

with chronic obstructive pulmonary disease: psychological

determinants: a cross sectional study. Health Qual Life

Outcomes. 2013;11:190. doi: 10.1186/1477-7525-11-190

Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG.

Prevalence and risk factors for depressive symptoms in persons

with chronic obstructive pulmonary disease. J Gen Int Med.

;23(11):1757-62. doi: 10.1007/s11606-008-0749-z

Vogele C, Von Leupoldt A. Mental disorders in chronic obstructive

pulmonary disease (COPD). Respir Med. 2008;102(5):764-73.

doi: 10.1016/j.rmed.2007.12.006

Kühl K, Schürmann W, Rief W. Mental disorders

and quality of life in patients with COPD and their spouses.

Int J Chron Obstruct Pulmon Dis [Internet]. 2008 [cited 2020

June 17];3(4):727-36. Available from: www.ncbi.nlm.nih.gov/

pmc/articles/PMC2650604/pdf/COPD-3-727.pdf

Stone RA, Lowe D, Potter JM, Buckingham RJ, Roberts CM, Pursey

NJ. Managing patients with COPD exacerbation: does age matter?

Age Ageing. 2012;41(4), 461-68. doi: 10.1093/aging/afs039

Voogd JN, Wempe JB, Koëter GH, Postema K, van Sonderen

E, Ranchor AV. Depressive symptoms as predictors of

mortality in patients with COPD. Chest. 2009;135:619-25.

doi: 10.1378/chest.08-0078

Pooler A, Beech R. Examining the relationship between anxiety

and depression and exacerbations of COPD which result in

hospital admission: a systematic review. Int J Chron Obstruct

Pulmon Dis. 2014;9:315-30. doi: 10.2147/COPD.S53255

Li LSK, Caughey GE, Johnston KN. The association between

co-morbidities and physical performance in people with chronic

obstructive pulmonary disease: A systematic review. Chron

Respir Dis. 2014;11(1):3-13. doi: 10.1177/1479972313516879

Di Marco F, Terraneo S, Roggi MA, Repossi AC, Pellegrino

GM, Veronelli A. Physical activity impairment in depressed

COPD subjects. Respir Care. 2014;59(5):726-34. doi: 10.4187/

respcare.02848

Altenburg WA, Bossenbroek L, De Greef MH, Kerstjens HA,

Ten Hacken NH, Wempe JB. Functional and psychological

variables affect daily physical activity in patients with COPD:

A structural equation model. Respir Med. 2013;107(11):1740-7.

doi: 10.1016/j.rmed.2013.06.002

Bendixen HJ, Wæhrens E, Wilcke JT, Sørensen LV. Selfreported quality of ADL task performance among

patients with COPD exacerbations. Scand J Occup Ther.

;21(4):313-20. doi: 10.3109/11038128.2014.899621

Chatila WM, Thomashow BM, Minai OA, Criner GJ, Faça BJ.

Comorbidities in chronic obstructive pulmonary disease. Proc

Am Thorac Soc. 2008;5:549-55. doi: 10.1513/pats.200709-148ET

Global Initiative for Chronic Obstructive Lung Disease. Global

Strategy for the Diagnosis, Management and Prevention of

COPD. Fontana; 2014.

Hornikx M, Van Remoortel H, Demeyer H, Camillo CAM, Decramer

M, Janssens W, Troosters T. The influence of comorbidities on

outcomes of pulmonary rehabilitation programs in patients

with COPD: a systematic review. Biomed Res Int. 2013;26:8.

doi: 10.1155/2013/146148

Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of

depressive symptoms in patients with chronic obstructive

pulmonary disease: a systematic review, meta-analysis and

meta-regression. Gen Hosp Psychiatry. 2011;33(3):217-23.

doi: 10.1016/j.genhosppsych.2011.03.009

Carvalho NS, Ribeiro RP, Ribeiro M, Nunes MPT, Cukier A, Stelmach

R. Asma e doença pulmonar obstrutiva crônica: uma comparação

entre variáveis de ansiedade e depressão. J Bras Pneumol.

;33(1):1-6. doi: 10.1590/S1806-37132007000100004

Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF,

Pitta F. Validação do Modified Pulmorary Status and Dyspnea

Questionnaire e da escala do Medical Research Council

para uso em pacientes com doença pulmonar obstrutiva

crônica no Brasil. J Bras Pneumol. 2008;34(12):1008-18.

doi: 10.1590/S1806-37132008001200005

Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH,

Wang YP. V alidation of the Brazilian Portuguese version of

the Beck Depression Inventory-II in a community sample. Rev

Bras Psiq. 2012;34:389-94. doi: 10.1016/j.rbp.2012.03.005

Quilty LC, Zhang KA, Bagby RM. The latent symptom

structure of the Beck Depression Inventory-II in outpatients

with major depression. Psychol Assess. 2010;22(3):603-8.

doi: 10.1037/a0019698

Oliveira MTS, Gonçalves M. Doença pulmonar obstrutiva

crônica e sintomas psiquiátricos: uma revisão de literatura.

Psych On-line Br [Internet]. 2015 [cited 2020 June 17];20(3).

Available from: www.polbr.med.br/ano15/prat0315.php

González-Gutiérrez MV, Velázquez JG, García CM, Maldonado

FC, Jiménez FJG, Vargas FG. Predictive Model for Anxiety

and Depression in Spanish Patients with Stable Chronic

Obstructive Pulmonary Disease. Arch Bronconeumol.

;52(3):151-7. doi: 10.1016/j.arbres.2015.09.003

Dal Negro RW, Bonadiman L, Turco L. Prevalence of different

comorbidities in patients with COPD by gender and GOLD

stage. Multidiscip Respir Med. 2015;10(1):24. doi: 10.1186/

s40248-015-0023-2

Sievi NA, Senn O, Brack T, Brutsche MH, Frey M, Irani S. Impact

of comorbidities on physical activity in COPD. Respirology.

;20:413-18. doi: 10.1111/resp.12456

Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of Anxiety

and Depression on Chronic Obstructive Pulmonary Disease

Exacerbation Risk. Am J Respir Crit Care Med. 2012;185(9):918-23.

doi: 10.1164/rccm.201105-0939PP

Heckler M, Weingartner R, Moreira JS, Prezzi S, Tombini N.

Prevalência de depressão em pacientes com doença pulmonar

obstrutiva crônica. J Pneumol. 1997;23(5):231-6.

Wouters EFM, Celis MPM, Breyer MK, Rutten EPA, GraatVerboom L, Spruit MA. Co-morbid manifestations in COPD.

Respir Med: COPD Update. 2007;3:135-51. doi: 10.1016/j.

rmedu.2007.08.003

van Manen JG, Bindels PJE, IJzermansa CJ, van der Zee JS,

Bottema BJAM, Schadé E. Prevalence of comorbidity in

patients with a chronic airway obstruction and controls over

the age of 40. J Clin Epidemiol. 2001;54:287-93. doi: 10.1016/

S0895-4356(01)00346-8

Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz

PT. Sex, Depression, and Risk of Hospitalization and Mortality

in Chronic Obstructive Pulmonary Disease. Arch Int Med.

;167(21):2345-53. doi: 10.1001/archinte.167.21.2345

Ng TP, Niti M, Fones C, Yap KB, Tan W-C. Co-morbid

association of depression and COPD: A population-based

study. Respir Med. 2009;103(6):895-901. doi: 10.1016/

j.rmed.2008.12.010

Velloso M, Jardim JR. Functionality of patients with chronic

obstructive pulmonary disease: energy conservation

techniques. J Brasil Pneumol. 2006;32(6):580-6. doi: 10.1590/

S1806-37132006000600017

Maoua M, El Maalel O, Abdelghani A, Boughattas W, Kalboussi

H, Chatti S. Impact of COPD on quality of life and mental

health among one hundred Tunisian patients. Rev Pneumol

Clin. 2014;70(4):195-202. doi: 10.1016/j.pneumo.2013.11.009

Costa GMO, Santos RCAS, Marinho PEM. Atividade de

vida diária e sintomas depressivos em pacientes com

doença pulmonar obstrutiva crônica. ConScientiae Saúde.

;16(4):402-8. doi: 10.5585/ConsSaude.v16n4.7662

Karloh M, Araujo CLP, Gulart AA, Reis CM, Steidle LJM, Mayer

AF. The Glittre-ADL test reflects functional performance

measured by physical activities of daily living in patients with chronic obstructive pulmonary disease. Braz J Phys

Ther. 2016;20(3):223-30. doi: 10.1590/bjpt-rbf.2014.0155

Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction

in patients with chronic obstructive pulmonary disease. Int

J Chron Obstruct Pulmon Dis [Internet]. 2008 [cited 2020

June 17];3(4):637-58. Available from: www.ncbi.nlm.nih.gov/pmc/

articles/PMC2650609/pdf/COPD-3-637.pdf

Mador MJ, Boskanat K. Steletal muscle dysfunction in chronic

obstructive pulmonary disease. Respir Res. 2001;2(4):216-24.

doi: 10.1186/rr60

Downloads

Published

2020-03-03

Issue

Section

Original Research

How to Cite

Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms. (2020). Fisioterapia E Pesquisa, 27(2), 194-201. https://doi.org/10.1590/1809-2950/19018827022020